Clinical Trial Update: MADIT ASIA Cardiac Resynchronization Trial [Phase 3]

View source ↗

Summary

The Phase 3 MADIT ASIA Cardiac Resynchronization Trial sponsored by Boston Scientific was terminated; it enrolled patients with congestive heart failure and lef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure Systolic
• Left Bundle Branch Block

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Congestive Heart Failure, Left Bundle Branch Block | Phase 3 | Status: TERMINATED